Doctor of Philosophy in Interdisciplinary Oncology (PhD)
The Interdisciplinary Oncology program (IOP) is a graduate program designed to appeal to a broad range of students interested in cancer research. IOP offers advanced study and research in a variety of fields relating to oncology. Those fields include: molecular and cellular biology, genetics, biophysics, bioinformatics, pharmaceutical sciences, radiological sciences, immunology, molecular pathology, sociobehavioral studies, epidemiology and health economics. The goal of the program is to provide graduate students from diverse backgrounds, with an education in a number of disciplines relating to oncology, and to provide training opportunities for intensive training in specialized aspects of cancer research. For more than ten years, the program has been training the next generation of cancer research leaders.
What makes the program unique?
IOP integrates the diverse areas of oncology by offering two required courses which provide an interdisciplinary perspective on oncology in a form that is accessible to students from diverse backgrounds. The elective courses provide intensive training in one or more subjects specific to the student's research, and also gives the student an opportunity to gain expertise in other disciplines that have potential for synergy with their primary specialization. Students have access to clinicians and university faculty through the world-renowned BC Cancer Agency, to get a practical perspective on oncology treatments and outcomes. An innovative rotation course is a unique option for students to gain hands-on experience by rotating through specialty laboratories and by shadowing clinicians.
TOEFL (ibT) Overall Score Requirement
IELTS Overall Score Requirement
7 students graduated between 2005 and 2013: 1 is in a non-salaried situation; for 0 we have no data (based on research conducted between Feb-May 2016). For the remaining 6 graduates:
Sample Employers in Higher EducationQueen's University Belfast
University of Toronto
Sample Employers Outside Higher EducationJohnson and Johnson Inc.
Princess Margaret hospital
RepliCel Life Sciences Inc.
BC Cancer Agency
Sample Job Titles Outside Higher EducationSenior Scientist
PhD Career Outcome SurveyYou may view the full report on career outcomes of UBC PhD graduates on outcomes.grad.ubc.ca.
DisclaimerThese data represent historical employment information and do not guarantee future employment prospects for graduates of this program. They are for informational purposes only. Data were collected through either alumni surveys or internet research.
Tuition / Program Costs
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,600.60||$2,811.98|
|Tuition per year||$4,801.80||$8,435.94|
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$899.00 (approx.)|
|Costs of living (yearly)||starting at $16,453.00 (check cost calculator)|
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
Admissions data refer to all UBC Vancouver applications, offers, new registrants for each year, May to April [data updated: 8 April 2016]. Enrolment data are based on March 1 snapshots.
Upcoming Doctoral Exams
Friday, 26 May 2017 - 1:00pm - Dorothy Lam Boardroom, BC Cancer Research Centre, 675 W. 10th Avenue
Monday, 26 June 2017 - 2:30pm - Dorothy Lam Boardroom, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC
This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.
Aparicio, Samuel (Breast cancer, genome sequencing )
Bally, Marcel Bertran (Pancreas centre)
Baumbusch, Jennifer (long-term residential care, family caregiving, Intellectual Disability, nursing care of older adults )
Benard, Francois (Medical isotopes Radioisotopes Nuclear Medicine Cancer Imaging Molecular imaging of cancer Radionuclide therapy, Cancer division, radiology, pancreas centre)
Brooks-Wilson, Angela (human genetics, cancer genetics, cancer families, longevity, Super seniors, genetic susceptibility)
Brown, Carolyn Janet (Epigenetic control of gene expression, X-chromosome inactivation, Long non-coding RNAs, XIST RNA, Genes escaping X-chromosome inactivation, DNA methylation)
Burgess, Michael (Philosophy and social sciences, ethics and social policy in the areas of genomics, genetics and biotechnology (health, agriculture and environment))
Buttyan, Ralph (Kidneys, Urinary System, Benign Bladder Dysfunctions)
Campbell, Kristin (Exercise, cancer prevention, cancer rehabilitation, cancer survivorship, physical activity, biomarkers, energy balance, obesity )
Cox, Michael (genetic testing, experiences of hereditary risk, social and ethical implications of genetics, interpersonal and family communication, qualitative research, narrative and story, Prostate cancer)
Dedhar, Shoukat (molecular biology, molecular biology as it relates to disease; developing new theraputics for cancer; how brain cells (neurons)make connections, therapeutics for cancer; molecular genetics and cancer; medical research, cancer, inflammatory diseases, cariovascular diseases, Cellular proteins, extracellular martrix, integrins, signal transduction, calreticulin, protein kinase, gene expression, cell differentiation)
Duronio, Vincent (Signal transduction, enzymes, cell regulation, programmed cell death, apoptosis, protein kinase, phosphorylation networks, oxidized LDL, macrophages, gene regulation)
Eaves, Constance Jean (Normal and leukemic stem cells, normal and malignant breast stem cells)
Gleave, Martin (Infectious diseases, interdisciplinary oncology, prostate)
Gotay, Carolyn (cancer prevention, behaviour change, risk factors, quality of life, clinical trials, survivorship, health disparities, Cancer Prevention Centre, worksite wellness, workplace wellness, shift work, sleep, breast cancer, obesity, nutrition, physical activity, exercise, chronic disease, chronic disease prevention, Cancer prevention, eliminating occupational exposure to carcinogens, assessing worksite health promotion programs, reducing breast cancer risks, improving sleep quality to reduce breast cancer-related impacts of shiftwork, and improving health outcomes for prostate cancer patients)
Guns, Emma (Prostate cancer, natural health products, dietary supploements, integrative oncology)
Hieter, Philip (Molecular biology of eukaryotic chromosome transmission )
Holt, Robert (Immunogenetics, Metagenomics - Infectious agents in Cancer, Cancer Genomes, Neurobiology, DNA Sequencing)
Recent Doctoral Citations
- Dr. Rebecca Macalpine Towle
"Dr. Towle analyzed the molecular profiles of the different stages of progression in oral squamous cell carcinoma. She further investigated several genes that were frequently deregulated in the premalignant stage of this disease in order to understand their role in this disease. This research contributes to our understanding of the development and progression of oral cancer." (November 2016)
- Dr. Spencer David Martin
"Dr. Martin developed personalized vaccines targeting tumor-specific mutations in mouse models of cancer. He also identified a subset of human ovarian cancer patients most likely to benefit from these vaccines. His research will help select cancer patients for immunotherapy and improve the efficacy of anti-cancer vaccines." (November 2016)
- Dr. Sze Ue Luk
"Dr. Luk studied new therapeutic targets in prostate cancers. She identified a specific protein, called BIRC6, that is critical in the survival of prostate cancer and developed a new agent targeting this molecule. Her research supports that anti-BIRC6 agents may represent a new treatment for patients with advanced prostate cancer." (November 2016)
- Dr. Guillaume Paul Amouroux
"Dr. Amouroux studied and developed cancer targeting agents mimicking kinins, in order to be used for non-invasive imaging in patients using Positron Emission Tomography. He successfully established the most favorable features for this purpose, which carries great promises for cancer diagnostic and therapy." (November 2016)
- Dr. Joseph Cheong Chun Lau
"Nuclear imaging has a significant role in cancer management including diagnosis, staging, treatment planning and treatment monitoring. Dr. Lau developed radiotracers targeting carbonic anhydrase IX, a protein found in tumours. His research enables physicians to identify patients that can benefit from personalized therapies targeting this protein." (November 2016)